Divalproex Sodium Tablet, Delayed Release
Product Images NDC 63629-4278

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 63629-4278). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 01

Chemical structure of Divalproex Sodium, depicting the sodium salt form of valproic acid dimers with associated molecular groups, presented as a repeating unit with sodium ions.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 02

A bar chart comparing two studies measuring an outcome in percentage for placebo (PBO) and Divalproex Sodium (DVPX). Study 1 (YMRS) shows 26% for placebo and 60% for Divalproex Sodium. Study 2 (IMRS) shows 29% for placebo and 58% for Divalproex Sodium.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 03

A cumulative percentage plot depicting the reduction in Clinical Psychiatric Scale (CPS) rate among patients treated with Divalproex Sodium compared to placebo. The vertical axis shows percentage change from worsening to improvement, and the horizontal axis represents the percentage of patients. The solid line indicates Divalproex Sodium, showing greater improvement compared to the dashed placebo line.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 04

A comparative line graph showing the percentage reduction in CPS rate among patients treated with high dose versus low dose of a drug. The x-axis represents the percentage of patients, while the y-axis shows the percent reduction in CPS rate. The graph indicates improvement and worsening trends for both dose groups.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 05

A bar chart comparing two studies, each with two bars representing Placebo and Divalproex Sodium. The y-axis shows numerical values from 0 to 6, and in both studies, the Placebo bars are higher than the Divalproex Sodium bars, indicating a difference in measured outcomes between treatment and placebo groups.*

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 06

FDA Label Image

Lbl636294278

Label for Divalproex Sodium DR 500 mg delayed-release tablets, packaged by Bryant Ranch Prepack in Burbank, CA. The label includes a comparison to Depakote 500 mg tablets and indicates a package size of 60 tablets. Storage instructions specify room temperature (20°-25°C or 68°-77°F). The label displays the NDC 63629-4278, a lot number, and mentions Unichem Laboratories Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.